eli lilly weight loss

Order byBest matchMost fresh

Zepbound beats Wegovy for weight loss

This drug led to 50% more weight loss than Wegovy in head-to-head study

After 72 weeks, participants receiving the Zepbound injections lost an average of 50 pounds, or 20% of their body weight.

· 4h

HealthLeaders Media · 7h

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

· 1d · on MSN

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

· 22h

First head-to-head trial found Zepbound beats Wegovy for weight loss

· 1d

New study compares Wegovy and Zepbound for the first time

STAT5d

Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list

A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes drugs from compounding pharmacies.

Healio6h

Tirzepatide bests semaglutide for weight loss in adults with obesity

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the SURMOUNT-5 trial. As Healio previously reported,

5don MSN

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and diabetes drugs Zepbound and Mounjaro off a list of medicines in short supply,

12don MSN

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

Explore more

Wegovy

Zepbound